You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Latest News
PyroGenesis completes plasma torch system for Constellium aluminium furnace project
...
Foresee Pharmaceuticals receives positive CHMP opinion for CAMCEVI 21 mg
...
Great Novel Therapeutics' GNTbm-38 approved by US FDA for Phase I trial
...
Elicera Therapeutics reports complete metabolic responses in highest‑dose CARMA cohort
...
Johnson & Johnson reports US FDA approval of TECVAYLI plus DARZALEX FASPRO for RRMM
6 March 2026 - Healthcare products company Johnson & Johnson (J&J) (NYSE:JNJ) announced on Thursday that it has received approval from the US Food and Drug Administration (FDA) for its TECVAYLI (teclistamab-cqyv) plus DARZALEX FASPRO (daratum...
 
 
M2 Pharma brings you breaking news and information on the global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Latest Business & Financial News
Abbott announces quarterly dividend
Latest Generics News
Breckenridge Pharmaceutical launches Pomalidomide Capsules in US market
Latest News on Therapy Areas
Foresee Pharmaceuticals receives positive CHMP opinion for CAMCEVI 21 mg
Latest News on Policy & Regulation
PyroGenesis completes plasma torch system for Constellium aluminium furnace project
Latest Research & Development
Foresee Pharmaceuticals receives positive CHMP opinion for CAMCEVI 21 mg
Latest People News
Ensorcell adds new senior leadership team members
Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026